123 ANAESTHESIA LIMITED

🌿Early-stageactive
15474976 · ltd · incorporated 2024-02-09
Investment thesis
Growth-phase business — story-led; valuation sensitive to momentum.
Why interesting: Trading is scaling; acquirers paying for trajectory get disproportionate leverage.
Why risky: Price often leads fundamentals; dependency on founder often high.
🔒Estimated value
Upgrade to see
Turnover
year to Feb 2025
Net worth
£9.6k
book net assets
Opportunity
71/100
Strong
🔔
Follow this company (free)
Email alerts on filings, charges, director changes, gazette notices. No account needed.

Unsubscribe any time from any email. GDPR-respectful.

What this business does
Primary activity: General medical practice activities
Sector: Human health & social work
ALSO REGISTERED FOR
  • 86220Specialist medical practice activities
Investor take
Pursue
Strong opportunity: asset-holding vehicle with strong profile and acceptable with review structure.

Opportunity 71/100 (strong), bankability 70/100. High owner-dependency — earn-out structure likely required for clean transition. Share purchase looks the cleaner deal structure. Most likely exit: strategic trade sale (65/100).

Data confidence

Overall: medium (69/100)

Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.

Company profile
address, 2 SIC codes, incorporation date
100
Financials
1 year of iXBRL accounts extracted (no YoY comparison) + narrative notes parsed
50
Lenders & charges
Confirmed no charges registered
85
Directors & officers
2 officers (2 active, 2 linked, 2 with DOB)
90
Ownership & PSC
2 active PSC(s) of 2 total, 2 with control declared
90
Director network
Network not yet resolved
30
Filing history
8 filings
60
Gazette notices
No matching gazette notices (standard for active companies)
60
Opportunity Score
71/100Strong
PassWatchWorth a lookStrongExceptional 

Solid opportunity signal. Worth a dedicated memo and management meeting.

Business quality
60
Adequate — check latest filings for context.
Acquirability
55
Some acquirability indicators.
Risk profile
85
Few red flags.
Signal strength
90
Good data coverage for analysis.

Signals from accounts

Derived from iXBRL accounts · FRS 105 (micro)
Positive net assets
Net assets £9,627

Key financials

1 year extracted from filed iXBRL accounts
Cash
Net Worth
£10k
Current Assets
£23k
Current Liabilities

Financials

Extracted from Companies House accounts · FRS 105 (micro)
Metric2025-02-28
Total assets£9.6k
Current assets£23.4k
Net assets£9.6k

Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.

🔒Filing-note intelligence

1 signal detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.

Available from the Pro tier upwards.

See pricing →

Recent activity

Last 30 days
0
filings
Last 90 days
1
filing
  • 1 confirmation-statement
Last 180 days
2
filings
  • 1 confirmation-statement
  • 1 accounts
Counts from Companies House filing history.
Corporate timeline (9 events)Click to expand
  1. 2025-11-03
    📄
    accounts-with-accounts-type-micro-entity
    accounts · AA
  2. 2024-07-31
    📄
    change-to-a-person-with-significant-control
    persons-with-significant-control · PSC04
  3. 2024-07-31
    📄
    change-person-director-company-with-change-date
    officers · CH01
  4. 2024-07-31
    📄
    change-to-a-person-with-significant-control
    persons-with-significant-control · PSC04
  5. 2024-07-31
    📄
    change-person-director-company-with-change-date
    officers · CH01
  6. 2024-02-09
    🏢
    Company incorporated
    As 123 ANAESTHESIA LIMITED
  7. 2024-02-09
    SAFFER, Emily Michal, Dr appointed
    director
  8. 2024-02-09
    SAFFER, Simon Lloyd appointed
    director
  9. 2024-02-09
    📄
    incorporation-company
    incorporation · NEWINC

Owner dependency

71/100
High — earn-out structure required

Material founder dependency. Consider a 2-3 year earn-out and build in a handover plan before completion.

FACTORS
  • +Two-director setup: Only two active directors — typical of owner-managed SMEs but limits succession.
  • +Family involvement: Multiple officers share a surname — likely family business, which concentrates governance.
  • +Young company: Only 2.2 years old — management layer unlikely to be developed.

Succession & seller-readiness

36/100
Weak signal

Limited succession signal. Not a near-term off-market candidate.

SIGNALS
  • secondaryTwo-director governance: Small-team governance. Succession depth is thin but not absent.

Red flags

clean
No red flags detected from available public data. (This is not a clean bill of health — detailed accounts review still recommended.)

Shareholders & ownership

2 active beneficial owners
NameSharesVoting rightsNature of controlNotified
Dr Emily Michal Saffer
Individual · British · DOB 02/1980 · age 46
2550%
25–50%board control25-50% shares · 25-50% voting · board control09/02/2024
Mr Simon Lloyd Saffer
Individual · British · DOB 12/1980 · age 46
2550%
25–50%board control25-50% shares · 25-50% voting · board control09/02/2024

From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.

Similar companies

Active · Healthcare & medical · WD postcode area
CompanyEst. valueTurnoverNet worthStaffAgeOppDirector
164 ST ALBANS AVE LTD
14319577 · est 2022 · no financials extracted
3y
46 PHILLIN LIMITED
06411283 · est 2007 · no financials extracted
18y
A ESMAIL MEDICAL LTD
14055118 · est 2022 · no financials extracted
3y
AAMABUWA LIMITED
07579948 · est 2011 · no financials extracted
15y
AARTI OPTICS LTD
16739246 · est 2025 · no financials extracted
AAS SERVICE LTD
16990587 · est 2026 · no financials extracted
ABBAS DHALLA LTD
08031161 · est 2012 · no financials extracted
14y
ABBEYLEECARE LTD
14510450 · est 2022 · no financials extracted
3y
ABC CARE LIMITED
14132912 · est 2022 · no financials extracted
3y
ABC HILLINGDON LTD
08094566 · est 2012 · no financials extracted
13y
ABC ORAL HEALTHCARE LTD
07708268 · est 2011 · no financials extracted
14y
ABCARES LIMITED
09508331 · est 2015 · no financials extracted
11y
Peers ranked by estimated value, then turnover, then opportunity score.See all →
🔒Tailored diligence questions

7 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.

Available from the Pro tier upwards.

See pricing →
🔒Advanced scoring suite

Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.

Available from the Pro tier upwards.

See pricing →

Company details

Statusactive
Typeltd
Incorporated2024-02-09
Jurisdictionengland-wales
Primary SIC86210 — General medical practice activities

Registered office

5 Beaumont Gate
Shenley Hill
Radlett
Hertfordshire
WD7 7AR
England

Filing status

Accounts
Next due: 2026-11-30
Last made up to: 2025-02-28
Confirmation statement
Next due: 2027-02-22
Last: 2026-02-08

Officers (2 active · 0 resigned)

SAFFER, Emily Michal, Dr
director · ~46y · appointed 2024-02-09
View their other companies + combined net worth →
Active
SAFFER, Simon Lloyd
director · ~46y · appointed 2024-02-09
View their other companies + combined net worth →
Active

Click a director name to see their full track record across all companies.

Recent filings (8 total)

confirmation-statement-with-no-updates
confirmation-statement · CS01
2026-02-18
accounts-with-accounts-type-micro-entity
accounts · AA
2025-11-03
confirmation-statement-with-no-updates
confirmation-statement · CS01
2025-03-14
change-to-a-person-with-significant-control
persons-with-significant-control · PSC04
2024-07-31
change-person-director-company-with-change-date
officers · CH01
2024-07-31
change-to-a-person-with-significant-control
persons-with-significant-control · PSC04
2024-07-31
change-person-director-company-with-change-date
officers · CH01
2024-07-31
incorporation-company
incorporation · NEWINC
2024-02-09